Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Research advances in metabolism 2017.
Perakakis N, Ghaly W, Peradze N, Boutari C, Batirel S, Douglas VP, Mantzoros CS. Perakakis N, et al. Among authors: peradze n. Metabolism. 2018 Jun;83:280-289. doi: 10.1016/j.metabol.2018.01.018. Epub 2018 Feb 10. Metabolism. 2018. PMID: 29378200 No abstract available.
Follistatins in glucose regulation in healthy and obese individuals.
Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS. Perakakis N, et al. Among authors: peradze n. Diabetes Obes Metab. 2019 Mar;21(3):683-690. doi: 10.1111/dom.13572. Epub 2018 Dec 3. Diabetes Obes Metab. 2019. PMID: 30393997 Free PMC article. Clinical Trial.
Research developments in metabolism 2018.
Peradze N, Farr OM, Mantzoros CS. Peradze N, et al. Metabolism. 2019 Feb;91:70-79. doi: 10.1016/j.metabol.2018.11.011. Epub 2018 Nov 29. Metabolism. 2019. PMID: 30503805 Review. No abstract available.
Circulating levels of the components of the GH/IGF-1/IGFBPs axis total and intact IGF-binding proteins (IGFBP) 3 and IGFBP 4 and total IGFBP 5, as well as PAPPA, PAPPA2 and Stanniocalcin-2 levels are not altered in response to energy deprivation and/or metreleptin administration in humans.
Pilitsi E, Peradze N, Perakakis N, Mantzoros CS. Pilitsi E, et al. Among authors: peradze n. Metabolism. 2019 Aug;97:32-39. doi: 10.1016/j.metabol.2019.05.004. Epub 2019 May 17. Metabolism. 2019. PMID: 31103608 Clinical Trial.
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial.
Peradze N, Farr OM, Perakakis N, Lázaro I, Sala-Vila A, Mantzoros CS. Peradze N, et al. Cardiovasc Diabetol. 2019 Oct 31;18(1):141. doi: 10.1186/s12933-019-0945-7. Cardiovasc Diabetol. 2019. PMID: 31672146 Free PMC article. Clinical Trial.
Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials.
Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, Upadhyay J, Alexandrou A, Mantzoros CS. Perakakis N, et al. Among authors: peradze n. Metabolism. 2019 Dec;101:153997. doi: 10.1016/j.metabol.2019.153997. Epub 2019 Oct 28. Metabolism. 2019. PMID: 31672446 Clinical Trial.
The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis.
Perakakis N, Joshi A, Peradze N, Stefanakis K, Li G, Feigh M, Veidal SS, Rosen G, Fleming M, Mantzoros CS. Perakakis N, et al. Among authors: peradze n. Hepatol Commun. 2020 Jul 28;4(9):1302-1315. doi: 10.1002/hep4.1558. eCollection 2020 Sep. Hepatol Commun. 2020. PMID: 32923834 Free PMC article.
38 results